# An Integrated Multi-Omics Analysis Identifies Oxeiptosis-Related Biomarkers in Diabetic Retinopathy

**Authors:** Jiaoyu Deng, Pengfei Ge, Ying Gao, Hong-Ying Li, Yifan Lin, Yangyang Lu, Haiyue Xie, Dianbo Xu, Ping Xie, Zizhong Hu

PMC · DOI: 10.3390/biomedicines13112789 · 2025-11-15

## TL;DR

This study identifies new biomarkers for diabetic retinopathy by analyzing oxidative stress-related genes and their roles in disease progression.

## Contribution

The novel contribution is the integration of multi-omics data to identify oxeiptosis-related genes as potential biomarkers and therapeutic targets in diabetic retinopathy.

## Key findings

- Oxeiptosis scores were significantly elevated in diabetic retinopathy blood samples.
- CASP2 and PLEC were identified as hub genes associated with disease progression and immune activation.
- A diagnostic nomogram using CASP2 and PLEC achieved strong predictive accuracy for diabetic retinopathy.

## Abstract

Background: Diabetic retinopathy (DR), a leading cause of blindness, lacks early biomarkers and mechanism-targeted therapies. While oxidative stress drives DR pathogenesis, the role of oxeiptosis—a reactive oxygen species-induced, caspase-independent cell death pathway—remains largely unexplored. Methods: We integrated transcriptomic profiling (GSE221521: 69 DR vs. 50 controls), two-sample Mendelian randomization (MR) using blood cis-eQTLs (GTEx) as instruments and DR GWAS (FinnGen R12) as outcome, machine learning-based feature selection (SVM-RFE and Boruta algorithms), and single-cell RNA sequencing (scRNA-seq) analysis (GSE165784). Functional enrichment, immune deconvolution (CIBERSORT), and diagnostic nomogram construction were performed. We validated the key genes using human retinal microvascular endothelial cells (hRMECs) treated with high glucose (30 mM). Results: Oxeiptosis scores were elevated in DR blood samples (p < 0.001). MR analysis identified five putative causal genes: CASP2 (OR = 1.067), PLEC (OR = 1.035) and FBN2 (OR = 1.016) as risk factors, and CYP27A1 (OR = 0.960) and GPD2 (OR = 0.958) as protective factors. SVM-RFE and Boruta algorithms confirmed CASP2 and PLEC as hub genes. A nomogram incorporating both genes achieved robust DR prediction (AUC = 0.811). Functional analysis associated these genes with innate immune activation and extracellular matrix reorganization. Single-cell transcriptomics revealed PLEC was markedly overexpressed in disease-relevant cells (fibroblasts, endothelial cells), whereas CASP2 exhibited a distinct pattern, with notable enrichment in retinal CD8+ T cells. Both genes were associated with a pro-inflammatory shift in the immune landscape. Their upregulation was validated in independent datasets and high-glucose-stressed retinal cells. Conclusions: This study establishes an integrated multi-omics framework implicating oxeiptosis-related pathways in DR and nominates CASP2 and PLEC as putatively causal, biologically relevant candidate biomarkers and potential therapeutic targets.

## Linked entities

- **Genes:** CASP2 (caspase 2) [NCBI Gene 835], PLEC (plectin) [NCBI Gene 5339], FBN2 (fibrillin 2) [NCBI Gene 2201], CYP27A1 (cytochrome P450 family 27 subfamily A member 1) [NCBI Gene 1593], GPD2 (glycerol-3-phosphate dehydrogenase 2) [NCBI Gene 2820]
- **Chemicals:** doxorubicin (PubChem CID 31703)
- **Diseases:** diabetic retinopathy (MONDO:0005266)

## Full-text entities

- **Genes:** FBN2 (fibrillin 2) [NCBI Gene 2201] {aka CCA, DA9, EOMD}, CYP27A1 (cytochrome P450 family 27 subfamily A member 1) [NCBI Gene 1593] {aka CP27, CTX, CYP27}, GPD2 (glycerol-3-phosphate dehydrogenase 2) [NCBI Gene 2820] {aka GDH2, GPDM, mGDH, mGPDH}, PLEC (plectin) [NCBI Gene 5339] {aka EBS1, EBS5A, EBS5B, EBS5C, EBS5D, EBSMD}, CASP2 (caspase 2) [NCBI Gene 835] {aka CASP-2, ICH1, MRT80, NEDD-2, NEDD2, PPP1R57}
- **Diseases:** blindness (MESH:D001766), DR (MESH:D003930), inflammatory (MESH:D007249)
- **Chemicals:** glucose (MESH:D005947), reactive oxygen species (MESH:D017382), Oxeiptosis (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** hRMECs — Homo sapiens (Human), Transformed cell line (CVCL_0307)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12650381/full.md

---
Source: https://tomesphere.com/paper/PMC12650381